The global ai in medical imaging market was valued at USD 1.85 billion in 2025. The market is projected to grow from USD 2.4 billion in 2026 to USD 19.58 billion by 2034, exhibiting a compound annual growth rate of 30% during the forecast period. Contrive Datum Insights presents this information in its report titled "Ai In Medical Imaging Market Size, Share & Industry Analysis, By Product (CT Scanners, MRI Systems, Ultrasound Scanners, Optical Coherence Tomography Devices, Others), End use (Hospital and healthcare providers, Patients, Pharmaceuticals and Biotechnology companies, Healthcare payers, Others), Application (Oncology, Cardiovascular, Neurology, Breast (Mammography), Digital Pathology, Lung (Respiratory System), Liver (GI), Oral Diagnostics, Other), Ai technology (Deep Learning, Computer Vision), Component (Software, Hardware, Services), and Regional Forecast, 2026-2034".
Artificial intelligence in medical imaging covers software and integrated hardware that applies machine learning, most often deep learning and computer vision, to acquire, reconstruct, triage or interpret diagnostic images such as CT, MRI, ultrasound and optical coherence tomography scans. Buyers include hospitals and imaging centers seeking faster read times and fewer missed findings, imaging equipment makers embedding algorithms into new scanners, and pharmaceutical or biotechnology sponsors using image analysis in clinical trials. The category spans standalone diagnostic-support software, cloud-hosted image-analysis platforms and AI modules bundled directly into scanner consoles.
Expanding regulatory clearances for AI-enabled imaging software
Expanding regulatory clearances for AI-enabled imaging software is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 30% a year, the product lines exposed to it move fastest: Optical Coherence Tomography Devices compounds at 35.8%, taking its share of revenue from 8% to 12% and its value from USD 0.148 billion to USD 2.35 billion.
A more favourable outcome is possible. If regulatory clearances accelerate and major payers adopt AI-imaging reimbursement codes faster than currently scheduled, pulling forward hospital purchasing across all regions, 2034 revenue reaches USD 22.517 billion instead of the USD 19.58 billion the base case carries.
The downside is specific. Reimbursement coding stalls and hospital capital budgets tighten, delaying AI-imaging software purchases and slowing the shift from pilot programs to system-wide deployment, and 2034 revenue lands at USD 16.643 billion. CT Scanners is the drag, 32% of the 2025 base compounding at 28.1% while the market runs at 30%.
Key Players Compete on CT Scanners Volume and Optical Coherence Tomography Devices Growth
Suppliers here are separated by product, not by geography. The incumbent position is CT Scanners: 32% of 2025 revenue, USD 0.592 billion, and still 28% in 2034. The contested position is Optical Coherence Tomography Devices at 35.8% growth. Few suppliers hold both, which is why a market of USD 1.85 billion supports as many participants as it does.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| End use | Hospital and healthcare providers | 55% · USD 1.017 billion | Healthcare payers 33.3% |
| Application | Oncology | 24% · USD 0.443 billion | Digital Pathology 36.9% |
| Ai technology | Deep Learning | 68% · USD 1.258 billion | Computer Vision 32.5% |
| Component | Software | 55% · USD 1.018 billion | — |
- Based on regional analysis, North America led the global ai in medical imaging market in 2025 with 45% of global revenue at USD 0.833 billion, reaching USD 7.44 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 22% in 2025 to 30% in 2034, with revenue growing from USD 0.407 billion to USD 5.874 billion.
- Middle East and Africa stays the smallest contributor across the period: 4% of revenue in 2025 and 4% in 2034.
- By product, the largest line in 2025 was CT Scanners, at 32% of revenue and USD 0.592 billion.
- The fastest product line is Optical Coherence Tomography Devices, forecast to compound at 35.8% through the period.
- The United States is the largest single country market at USD 0.708 billion in 2025, 38.27% of global revenue.
Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by product, and by end use, application, ai technology and component. The headline total carries bear, base and bull cases at USD 16.643 billion and USD 22.517 billion by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.